Human hippocampal neurogenesis in adulthood, ageing and Alzheimer’s disease
Summary
This Nature study used single-nucleus multiomic profiling (snRNA-seq + snATAC–seq) of the human dentate gyrus across five cohorts — young adults (YA), healthy agers (HA), preclinical intermediate pathology (PCI), Alzheimer’s disease (AD) and SuperAgers (SA) — to map neurogenesis and its regulation in humans. Researchers identified neural stem cells (NSCs), neuroblasts and immature neurons and reconstructed a developmental trajectory from NSCs to mature granule neurons. The multiomic data reveal that changes in chromatin accessibility (DARs) are a stronger and earlier signature of ageing and cognitive decline than changes in mRNA levels (DEGs). PCI samples already show DAR downregulation in neuroblasts and immature neurons that progresses in AD, implicating synaptic-plasticity pathways. SuperAgers show a resilience signature: increased immature-neuron abundance, many upregulated DARs and distinct enhancer-driven regulons (eRegulons) that overlap partially with young adults. CA1 neurons, astrocytes and glutamatergic synaptic networks emerge as key players distinguishing successful from pathological ageing. The authors discuss limitations including sample size, inter-sample variability and post-mortem factors that may affect mRNA measurements.
Key Points
- Single-nucleus multiomics identified NSCs, neuroblasts and immature neurons in adult human dentate gyrus and reconstructed a developmental trajectory to mature granule neurons.
- Chromatin accessibility changes (DARs) are more numerous and earlier indicators of ageing and cognitive decline than differential gene expression.
- Preclinical (PCI) samples show DAR downregulation in neuroblasts and immature neurons that foreshadows changes seen in AD; implicated pathways relate to synaptic plasticity and neurotransmission.
- SuperAgers exhibit a resilience signature: more immature neurons, thousands of upregulated DARs in immature neurons and distinct eRegulon networks overlapping YA patterns.
- Distinct gene regulatory networks and TF motifs shift from stem-cell maintenance in NSCs to differentiation/maturation programs in immature neurons.
- HIPPI (hippocampal integrity) signature highlights CA1 neuron DEGs and astrocyte DARs linked to synaptic adhesion and glutamatergic signalling as markers of healthy cognitive ageing.
- Study limitations include modest sample numbers, inter-sample variability and potential post-mortem artefacts affecting mRNA but less so chromatin accessibility.
Author take
Punchy: This is a landmark multiomic map showing that adult human hippocampal neurogenesis exists as a definable trajectory and that epigenetic changes — not just RNA shifts — track ageing, preclinical decline and Alzheimer’s. The paper points to early chromatin changes in progenitors and to synaptic/plasticity pathways as potential intervention targets. If you work on ageing, AD or brain regeneration, the regulatory networks and DARs here are worth close inspection.
Why should I read this?
Short version: if you care about Alzheimer’s, memory or how new neurons might help the ageing brain, this saves you time. It’s one of the clearest human multiomic datasets linking stem-cell states, chromatin changes and disease progression — and it flags concrete molecular targets (DARs, eRegulons and synaptic pathways) that could be followed up in therapy or biomarker work.
Context and relevance
This work sits at the crossroads of neurogenesis, epigenetics and dementia research. It reconciles and extends conflicting human studies by using paired snRNA and snATAC data to define cell types and regulatory networks. The finding that chromatin accessibility alterations precede RNA-level changes in the transition from healthy ageing to preclinical pathology and AD is important: it suggests epigenetic markers could serve as earlier indicators or targets for interventions. The SuperAger resilience signature also provides a molecular foothold for studying preserved cognition in advanced age.